Project
AMG 145 20120138 OSLER
Completed ยท 2013 until 2017
Rickli Hans, Gemperle Michaela, Rigger Johannes
Type
Range
Units
Status
Start Date
End Date
Financing
Study Design
Brief description/objective
A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145
Study Phase: 3
Indication: Primary hyperlipidemia and mixed dyslipidemia
Primary Objective: To characterize the safety and tolerability of long-term administration of
AMG 145
Secondary Objectives:
To characterize efficacy of long-term administration of AMG 145 as assessed by low density
lipoprotein cholesterol (LDL-C) in subjects with primary hyperlipidemia and subjects with mixed
dyslipidemia.
Hypotheses:
The primary clinical hypothesis is that long-term exposure of AMG 145 will be safe and
well-tolerated in subjects with primary hyperlipidemia and subjects with mixed dyslipidemia.
Primary Endpoint:
Subject incidence of adverse events